Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
20 Nov 2014 Patients with Advanced Papillary RCC Respond Well to a Combination of Bevacizumab and Erlotinib Genitourinary cancers - Anticancer agents & Biologic therapy
17 Nov 2014 FDA Approves Bevacizumab in Combination with Chemotherapy for Platinum Resistant, Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
17 Nov 2014 Metatastatic Relapse and Survival After Radical Treatment in Patients with Localised Prostate Cancer and BRCA Mutations Genitourinary cancers - Translational research
14 Nov 2014 Ten Years of Progress in Translational Research in Oncology Translational research
12 Nov 2014 Lung Cancer Screening with Low-Dose CT Could Be Cost Effective Bioethics, legal and economic issues - Cancer prevention - Lung and other thoracic tumours
10 Nov 2014 Young Patients With Newly Diagnosed Colorectal Cancer Anticipated to Nearly Double by 2030 Cancer prevention - Cancer in Special Situations - Gastrointestinal cancers
07 Nov 2014 Olaparib in Patients with BRCA-Related Cancers Cancer in Special Situations - Anticancer agents & Biologic therapy
06 Nov 2014 Facilitating Global Development of Biosimilars Bioethics, legal and economic issues
05 Nov 2014 Ipilimumab Plus Sargramostim in Metastatic Melanoma Melanoma - Immuno-oncology
03 Nov 2014 Genomic Landscape of ccRCC in Central Europe Genitourinary cancers - Translational research
31 Oct 2014 Genomic Landscape of Papillary Thyroid Carcinoma Translational research - Endocrine cancers
30 Oct 2014 Study May Explain Why Erlotinib Doesn't Benefit Patients With Early-Stage Lung Cancer Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Oct 2014 Hormone Therapy Adherence in Early-Stage Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
28 Oct 2014 EMA Adopts a Positive Opinion for a New Indication for Enzalutamide Genitourinary cancers - Anticancer agents & Biologic therapy
27 Oct 2014 EMA Recommends Granting a Marketing Authorisation for Olaparib Gynaecologic malignancies - Anticancer agents & Biologic therapy